N/A
N=25
Evaluation of PillCam® Express Capsule Endoscopy Delivery System
Small Bowel Disease · Inflammatory Bowel Disease
Bottom Line
View on ClinicalTrials.gov: NCT01088646 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
May 2012
Primary outcome: Primary: Number of Participants With Successful Capsule Placement Into the Duodenum Using Capsule Delivery System — 25 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PillCam® Express Capsule Endoscopy Delivery System (Device)
- Age
- Pediatric, Adult, Older Adult · 2+ yrs
- Sex
- All
- Sponsor
- Medtronic - MITG
- Primary completion
- May 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Successful Capsule Placement Into the Duodenum Using Capsule Delivery System |
25 | — |
| SECONDARY Physician's Subjective Assessment of the Ease of Capsule Placement |
94; 126 | — |
Summary
The purpose of this study is to evaluate the safety and efficacy of a trans-endoscopic capsule placement Capsule Endoscopy Delivery System.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 2 years
- Subject scheduled for EGD endoscopy with a 2.8 mm (or greater) working channel
Exclusion criteria
- Subject is known or is suspected to suffer from bowel obstruction or bowel perforation at the time of presentation
- Subject has history of UGI tract surgery (e.g., Billroth I, Billroth II, esophagectomy, gastrectomy, bariatric procedure)
- Presence of an electro-medical device (pacemaker or internal cardiac defibrillator)
- Subject is pregnant
- Subject is expected to undergo a MRI examination within 7 days after ingestion of the capsule
- Subject has known allergy to conscious sedation medications
- Subject or legal guardian is not able to provide written informed consent
Data sourced from ClinicalTrials.gov (NCT01088646). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.